86541-62-0

Basic information

• Product Name: 1a,2,3,13c-tetrahydrobenzo[8,9]tetrapheno[1,2-b]oxirene-2,3-diol
• Synonyms: anti-3,4-Dihydroxy-1,2-epoxy-1,2,3,4-tetrahydrodibenz(a,h)anthracene
• CAS NO: 86541-62-0
• Molecular Formula: C₂₂H₁₆O₃
• Molecular Weight: 328.3606
• Mol File: 86541-62-0.mol
• Article Data: 2

Chemical Properties

• Boiling Point: 645.3°C at 760 mmHg
• Flash Point: 344.1°C
• Density: 1.476g/cm³
• Vapor Pressure: 1.56E-17mmHg at 25°C
• Refractive Index: 1.85
• CAS DataBase Reference: 1a,2,3,13c-tetrahydrobenzo[8,9]tetrapheno[1,2-b]oxirene-2,3-diol(CAS DataBase Reference)
• NIST Chemistry Reference: 1a,2,3,13c-tetrahydrobenzo[8,9]tetrapheno[1,2-b]oxirene-2,3-diol(86541-62-0)
• EPA Substance Registry System: 1a,2,3,13c-tetrahydrobenzo[8,9]tetrapheno[1,2-b]oxirene-2,3-diol(86541-62-0)

Safety Data

• Hazardous Substances Data: 86541-62-0(Hazardous Substances Data)

Usage

Complex organic compound

It is a complex organic compound with a highly fused and aromatic ring system.

Combination of benzene and tetraphene rings

The compound contains a combination of benzene and tetraphene rings, which contribute to its complex structure.

Epoxy group

The compound has an epoxy group, which is a three-membered cyclic ether with an oxygen atom.

Hydroxyl groups

The compound also contains hydroxyl groups, which are functional groups consisting of an oxygen atom bonded to a hydrogen atom.

Laboratory synthesis

This chemical is not commonly found in nature, but laboratory synthesis has been reported.

Potential reactivity and utility

The structure and functional groups of the compound suggest potential reactivity and utility in organic synthesis and medicinal chemistry.

Highly fused and rigid structure

The compound's highly fused and rigid structure may contribute to its potential biological activity.

Interest for further study

Due to its potential biological activity, the compound is a molecule of interest for further study in the fields of organic synthesis and medicinal chemistry.

Upstream product

• 66267-19-4 trans-3,4-dihydroxy-3,4-dihydrodibenzanthracene 
• 72378-85-9 C₃₆H₂₅BrO₄ 
• 72378-81-5 trans-3,4-bis(benzoyloxy)-3,4-dihydrodibenzanthracene 
• 72378-84-8 trans-3,4-bis(benzoyloxy)-1,2,3,4-tetrahydrodibenzanthracene 
• 1350662-18-8 (-)-(1R,2S,3R,4S)-2-bromo-1,3,4-trihydroxy-1,2,3,4-tetrahydrodibenz[a,h]anthracene 
• 1350662-17-7 (+)-(1S,2R,3S,4R)-2-bromo-1,3,4-trihydroxy-1,2,3,4-tetrahydrodibenz[a,h]anthracene 
• 1421-83-6 (-)-(3R,4R)-3,4-dihydroxy-3,4-dihydrodibenz[a,h]anthracene 
• 72378-83-7 1,4,7,8,11,14-Hexahydrodibenzanthracene 
• 57816-08-7 7,14-dihydrodibenz[a,h]anthracene 

Relevant articles and documents

Synthesis, absolute configuration, and bacterial mutagenicity of the 8 stereoisomeric vicinal diol epoxides at the terminal benzo ring of carcinogenic dibenz[ a,h ]anthracene

The synthesis of the 8 possible stereoisomeric diol epoxides (DEs) at the terminal benzo ring of carcinogenic dibenz[a,h]anthracene (DBA) is reported. trans-3,4-Dihydroxy-3,4-dihydro-DBA (1) afforded the 4 bay region DEs: the enantiomeric pairs of the ant